CAR T-Cell Immunotherapy in Neuroautoimmune Diseases: Focus on the Central Nervous System

作者
Fotis Demetriou,Maria C. Anagnostouli
出处
期刊:Biomedicines [Multidisciplinary Digital Publishing Institute]
卷期号:14 (2): 296-296 被引量:3
标识
DOI:10.3390/biomedicines14020296
摘要

The treatment of central nervous system (CNS) autoimmune diseases has evolved from broad immunosuppression toward targeted disease-modifying therapies (DMTs). While current DMTs effectively control inflammatory activity in many patients, unmet needs remain, including persistent compartmentalised CNS pathology, limited tissue penetration, and the cumulative burden of chronic therapy. Chimeric antigen receptor (CAR) T-cell therapy represents a novel "living" immunotherapy capable of antigen-specific cellular depletion. Although currently approved only for B-cell malignancies, CAR T-cells are increasingly being explored in CNS autoimmunity leveraging their capacity for autonomous cytotoxicity and expected access to immune cells within protected CNS niches following a potentially single intervention. In this review, we examine CAR T-cells in the context of CNS-autoimmunity, we outline principles derived from oncologic applications, assess current DMTs, their limitations and side effects, and define parameters where CAR T-cells may offer added value. We discuss biological and practical requirements for broader clinical application, as currently they are investigated only for the very severe and refractory cases where all alternative treatments have failed. We further review the plasticity of CAR constructs, distinguishing clinically advanced platforms from early proof-of-concept approaches. Finally, we summarise clinical experience from 15 patients with CNS autoimmunity treated with CAR T-cells and review ongoing or planned trials that include such patients. We conclude that CAR T-cell therapy remains investigational for severe, treatment-refractory disease, with future applicability dependent on demonstrable efficacy, safety, cost, and feasibility beyond existing DMTs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YangHuilin完成签到 ,获得积分10
1秒前
2秒前
2秒前
王王完成签到 ,获得积分10
3秒前
3秒前
key的应助被369ninja采纳,获得10
3秒前
kkk完成签到,获得积分10
4秒前
嘿嘿嘿完成签到 ,获得积分10
4秒前
赘婿的应助被晚生不才采纳,获得10
4秒前
5秒前
5秒前
5秒前
tangz完成签到,获得积分20
5秒前
风中完成签到,获得积分10
5秒前
小yang发布了新的文献求助10
6秒前
Atwish发布了新的文献求助10
6秒前
李子青完成签到,获得积分10
7秒前
潇洒的无声完成签到 ,获得积分10
8秒前
热心冷亦完成签到,获得积分10
8秒前
高贵幼枫完成签到 ,获得积分10
9秒前
10秒前
哈哈发布了新的文献求助30
11秒前
11秒前
小yang完成签到,获得积分10
12秒前
13秒前
13秒前
Jasper的应助被ygqchem采纳,获得10
14秒前
tx的应助被ling采纳,获得10
14秒前
15秒前
15秒前
小小菜完成签到 ,获得积分10
15秒前
感动的莞完成签到,获得积分10
15秒前
15秒前
wanghaoan完成签到,获得积分10
15秒前
科研通AI65的应助被makabaka采纳,获得10
16秒前
u711711发布了新的文献求助10
16秒前
illuminate完成签到 ,获得积分10
17秒前
昏睡的柜子完成签到,获得积分10
18秒前
邪恶猪屁完成签到 ,获得积分10
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190664
求助须知:如何正确求助?哪些是违规求助? 9577768
关于积分的说明 21854688
捐赠科研通 7789790
什么是DOI,文献DOI怎么找? 3436425
关于科研通互助平台的介绍 2560302
邀请新用户注册赠送积分活动 2483169